What is the purpose of Zoledronic 5mg Acid Injection?
Zoledronic 5mg Acid Injection(Zometa) is a drug that is used to treat elevated calcium levels in the blood that can be caused by cancer.
What is 5 mg of zoledronic acid?
The active ingredient in Zoledronic acid 5 mg is zoledronic acid. It’s part of a class of drugs known as bisphosphonates, and it’s used to treat osteoporosis in postmenopausal women and adult males, as well as osteoporosis caused by corticosteroid treatment for inflammation.
What are the Zoledronic Acid Injection side effects?
- and nausea is all common Zometa side effects.
- muscle/joint aches
- eyesight problems
- and a fatigued sensation is all flu-like symptoms. For more click here.
What is Zoledronic 5mg Acid Injection and what does it do?
Osteoporosis. A single intravenous infusion of 5 mg Zoledronic Acid administered once a year is suggested for the treatment of postmenopausal osteoporosis, osteoporosis in men, and osteoporosis associated with long-term systemic glucocorticoid therapy.
Is Zoledronic 5mg Acid Injection bad for your heart?
According to a study presented at the American Society for Bone and Mineral Research (ASBMR) 2017 Annual Meeting held September 8-11 in Denver, Colorado, patients treated with zoledronic acid had a higher risk of heart failure and other cardiovascular diseases.
What is the safety of Zoledronic 5mg Acid Injection?
Zoledronic acid exhibited an acceptable safety profile; no drug-related adverse events were reported. Even in high-risk individuals, ZA treatment enhanced bone health by increasing bone mineral density and decreasing bone turnover.
When you stop using Zoledronic 5mg Acid Injection, what happens?
The best time to take zoledronic acid has yet to be discovered. Doctors should consider discontinuing medication after 3 to 5 years in patients with osteoporosis who are at low risk of fracture. Patients who stop taking their medication should have their fracture risk assessed on a regular basis.
What is the half-life of Zoledronic Injection?
Zoledronic acid is a long-acting medicine. As a result, it lingers in your body for more than a year (probably more than 24 months). As a result, delaying treatment for a few months will not increase your risk of sustaining a fragility fracture or cause a major loss of bone mineral density.
Who should avoid zoledronic acid use?
Stage 4 chronic renal disease (severe) Stage 5 (failure) chronic renal disease with a likely decline in kidney function. a bone break in the upper leg that occurred unexpectedly and without warning.